Evidence map›Paper›PMID 38336944›Full record

ArticleNature communications2024

Evaluating vector competence for Yellow fever in the Caribbean.

Gaelle Gabiane, Chloé Bohers, Laurence Mousson, Thomas Obadia, Rhoel R Dinglasan, Marie Vazeille, Catherine Dauga, Marine Viglietta, André Yébakima, Anubis Vega-Rúa and 9 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Vector competence acrossJournal of virology · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 5 countries.

Gaelle GabianeInstitut Pasteur, Université Paris Cité, Arboviruses and Insect Vectors, Paris, France.
Chloé BohersInstitut Pasteur, Université Paris Cité, Arboviruses and Insect Vectors, Paris, France.
Laurence MoussonInstitut Pasteur, Université Paris Cité, Arboviruses and Insect Vectors, Paris, France.
Thomas ObadiaInstitut Pasteur, Université Paris Cité, Bioinformatics and Biostatistics Hub, Marseille, France.
Rhoel R DinglasanUniversity of Florida, Department of Infectious Diseases & Immunology and Emerging Pathogens Institute, College of Veterinary Medicine, Gainesville, FL, USA.ORCID 0000-0001-5433-8179
Marie VazeilleInstitut Pasteur, Université Paris Cité, Arboviruses and Insect Vectors, Paris, France.ORCID 0000-0003-4935-4662
Catherine DaugaInstitut Pasteur, Université Paris Cité, Arboviruses and Insect Vectors, Paris, France.
Marine VigliettaInstitut Pasteur, Université Paris Cité, Arboviruses and Insect Vectors, Paris, France.
André YébakimaVECCOTRA, Rivière Salée, Martinique, Marseille, France.
Anubis Vega-RúaInstitut Pasteur de Guadeloupe, Laboratory of Vector Control Research, Unit Transmission Reservoir and Pathogens Diversity, Les Abymes, Guadeloupe, Marseille, France.
Gladys Gutiérrez BugalloInstitut Pasteur de Guadeloupe, Laboratory of Vector Control Research, Unit Transmission Reservoir and Pathogens Diversity, Les Abymes, Guadeloupe, Marseille, France.ORCID 0000-0003-4415-7045
Rosa Margarita Gélvez RamírezCentro de Atención y Diagnóstico de Enfermedades Infecciosas, Fundación INFOVIDA, Bucaramanga, Colombia.ORCID 0000-0002-4851-1753
Fabrice SonorCentre de Démoustication et de Recherches Entomologiques, Lutte antivectorielle, Martinique, Marseille, France.
Manuel EtienneCentre de Démoustication et de Recherches Entomologiques, Lutte antivectorielle, Martinique, Marseille, France.
Nathalie Duclovel-PameAgence Régionale de Santé, Direction de la Santé Publique, Martinique, Marseille, France.
Alain BlateauAgence Régionale de Santé, Direction de la Santé Publique, Martinique, Marseille, France.
Juliette Smith-RavinGroupe de recherche Biospheres Université des Antilles, Campus de Schœlcher, Martinique, Marseille, France.
Xavier De LamballerieUnité des Virus Emergents (UVE), Aix Marseille Université, IRD 190, Inserm 1207, IHU Méditerranée Infection, Marseille, France.ORCID 0000-0001-7895-2720
Anna-Bella FaillouxInstitut Pasteur, Université Paris Cité, Arboviruses and Insect Vectors, Paris, France. anna-bella.failloux@pasteur.fr.ORCID 0000-0001-6890-0820
Institut Pasteur · FRCentre Hospitalier Universitaire de Martinique · MQInserm · FRInstitut Pasteur de la Guadeloupe · GPUniversity of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mosquito-borne disease, Yellow fever (YF), has been largely controlled via mass delivery of an effective vaccine and mosquito control interventions. However, there are warning signs that YF is re-emerging in both Sub-Saharan Africa and South America. Imported from Africa in slave ships, YF was responsible for devastating outbreaks in the Caribbean. In Martinique, the last YF outbreak was reported in 1908 and the mosquito Aedes aegypti was incriminated as the main vector. We evaluated the vector competence of fifteen Ae. aegypti populations for five YFV genotypes (Bolivia, Ghana, Nigeria, Sudan, and Uganda). Here we show that mosquito populations from the Caribbean and the Americas were able to transmit the five YFV genotypes, with YFV strains for Uganda and Bolivia having higher transmission success. We also observed that Ae. aegypti populations from Martinique were more susceptible to YFV infection than other populations from neighboring Caribbean islands, as well as North and South America. Our vector competence data suggest that the threat of re-emergence of YF in Martinique and the subsequent spread to Caribbean nations and beyond is plausible.

Indexed as

AedesYellow FeverAnimalsCaribbean RegionHumansMosquito VectorsUgandaWest IndiesYellow fever virus

Identifiers

PMID38336944
PMCPMC10858021
OpenAlexW4391682146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.